Description
Pegfilgrastim is a hematopoietic drug, it is sold under the brand name Peg. It it used for the treatment of febrile neutropenia and to increase the survival rate in patients receiving myelosuppressive doses of radiation.
It is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).
Pegfilgrastim was approved for medical use in the United States in January 2002, in the European Union in August 2002, and in Australia in September 2002.
List of available brand-name drugs in India for Pegfilgrastim
Branded Generic Drugs for Pegfilgrastim: Neupeg, Pegex, Peg-Grafeel, Peg Religrast, Peg, Glenstim, Pegg Frastim, Pegstim, Pegg Trust, Pegasta
NEWS / Updates
- Package leaflet: Information for the user Neulasta 6 mg solution for injection pegfilgrastim. [Revised 2021 Jun] [cited 2023 Feb 23]. Available from: https://www.medicines.org.uk/emc/files/pil.10091.pdf
- Patient Information Neulasta ® (nu-las-tah) (pegfilgrastim) injection Single-Dose Prefilled Syringe. (2021). Available at: https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Neulasta/neulasta_ppi_pt_english.pdf [Accessed 23 Feb. 2023].
- HIGHLIGHTS OF PRESCRIBING INFORMATION. (2019). Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125031s198lbl.pdf [Accessed 23 Feb. 2023].
- Parker, S.D. and Jacobs, T.F. (2020). Pegfilgrastim. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK532893/ [Accessed 23 Feb. 2023].
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
26 Sep 2024 | 05:03 AM (IST)
